Page last updated: 2024-08-22

olsalazine and Colitis

olsalazine has been researched along with Colitis in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's3 (42.86)18.2507
2000's1 (14.29)29.6817
2010's1 (14.29)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Hou, T; Li, Y; Liang, X; Lin, H; Liu, F; Otkur, W; Pei, S; Piao, HL; Qi, H; Wang, J; Xiang, K; Yang, R; Zhang, X; Zhou, H1
Erichsen, Jv; Hessmann, M; Hoffmeyer, A; Pahl, A; Sann, H1
Bauer, C; Dauer, M; Eigler, A; Endres, S; Freytag, P; Hallwachs, R; Kapp, JF; Landauer, N; Lehr, HA; Loher, F; Rieder, F; Schmall, K; Siegmund, B1
Axelsson, LG; Bylund-Fellenius, AC; Landström, E1
Garrelds, IM; van Dijk, AP; Wilson, JH; Zijlstra, FJ1
Baum, MD; Doman, DB1
Nadorp, JH; Scherpenisse, J; van den Bosch, JM; van der Valk, PD; van Hees, PA1

Other Studies

7 other study(ies) available for olsalazine and Colitis

ArticleYear
Aminosalicylates target GPR35, partly contributing to the prevention of DSS-induced colitis.
    European journal of pharmacology, 2023, Jun-15, Volume: 949

    Topics: Aminosalicylic Acid; Aminosalicylic Acids; Animals; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Mice; Mice, Inbred C57BL; NF-kappa B; Prodrugs; Receptors, G-Protein-Coupled

2023
Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice.
    Life sciences, 2013, Apr-09, Volume: 92, Issue:12

    Topics: Aminosalicylic Acids; Animals; Anti-Inflammatory Agents; Budesonide; Colitis; Colon; Cyclosporine; Dextran Sulfate; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Mesalamine; Mice; Mice, Inbred BALB C; Receptors, Prostaglandin E, EP4 Subtype; Thioguanine

2013
The specific type-4 phosphodiesterase inhibitor mesopram alleviates experimental colitis in mice.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 305, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aminosalicylic Acids; Animals; Colitis; Colon; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytokines; Dextran Sulfate; Dose-Response Relationship, Drug; Female; Interferon-gamma; Mice; Mice, Inbred BALB C; Oxazoles; Phosphodiesterase Inhibitors; Tumor Necrosis Factor-alpha

2003
Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine.
    Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:9

    Topics: Aminosalicylic Acids; Animals; Colitis; Dextran Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Mice; Mice, Inbred BALB C; Mice, Nude; Outcome Assessment, Health Care; Sulfasalazine; Survival Analysis; Treatment Outcome

1998
Experimental colitis in mice: effects of olsalazine on eicosanoid production in colonic tissue.
    Agents and actions, 1992, Volume: Spec No

    Topics: Aminosalicylic Acids; Animals; Arachidonic Acid; Calcimycin; Carrageenan; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Eicosanoids; Female; Intestinal Mucosa; Mice; Mice, Inbred BALB C

1992
Olsalazine sodium can cause myopia that can be clinically confused with the uveitis of inflammatory bowel disease.
    The American journal of gastroenterology, 1992, Volume: 87, Issue:11

    Topics: Adult; Aminosalicylic Acids; Colitis; Crohn Disease; Diagnosis, Differential; Female; Humans; Myopia; Uveitis

1992
Olsalazine as an alternative therapy in a patient with sulfasalazine-induced eosinophilic pneumonia.
    Journal of clinical gastroenterology, 1988, Volume: 10, Issue:2

    Topics: Adult; Aminosalicylic Acids; Colitis; Crohn Disease; Humans; Male; Pulmonary Eosinophilia; Sulfasalazine

1988